Profile data is unavailable for this security.
About the company
Eyebright Medical Technology (Beijing) Co Ltd is a China-based company mainly engaged in the manufacturing of ophthalmic medical devices. The Company's products cover three major areas: ophthalmic surgical treatment, myopia prevention and control, and vision health care. The surgical treatment products mainly include the series of basic and functional artificial intraocular lenses such as Proming and Quanshi. The myopia prevention and control products mainly include iBright brand corneal reshaping lenses, as well as defocusing frame lenses, defocusing soft lenses, and daily rigid contact lenses. The vision health products mainly include transparent contact lenses and colored contact lenses from brands such as Lebleu, Ocula, and TOPPOP.
- Revenue in CNY (TTM)1.48bn
- Net income in CNY360.97m
- Incorporated2010
- Employees2.29k
- LocationEyebright Medical Technology (Beijing) Co LtdBuilding 12#12 Changsheng Road, Changping RoadBEIJING 102200ChinaCHN
- Phone+86 1 089748322
- Fax+86 1 089747942
- Websitehttp://www.ebmedical.com/
More ▼
Mergers & acquisitions
| Acquired company | 688050:SHH since announced | Transaction value |
|---|---|---|
| Demei United (Chongqing) Medical Technology Co Ltd | -7.67% | 99.43m |
Data delayed at least 15 minutes, as of Mar 03 2026.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.22bn | 2.81k | 39.65 | 2.37 | -- | 4.52 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Beijing Wandong Medical Technolgy Co Ltd | 1.62bn | 14.41m | 10.62bn | 1.19k | 906.96 | 2.27 | -- | 6.56 | 0.0167 | 0.0167 | 2.26 | 6.66 | 0.2937 | 2.73 | 2.99 | 1,360,016.00 | 0.2623 | 4.51 | 0.304 | 5.21 | 31.59 | 42.82 | 0.8933 | 14.91 | 4.80 | -- | 0.0039 | 43.25 | 23.26 | 9.18 | -16.54 | -1.40 | -1.39 | 21.06 |
| Sansure Biotech Inc | 1.67bn | 271.49m | 10.72bn | 2.35k | 41.79 | 1.50 | -- | 6.42 | 0.4427 | 0.4427 | 2.45 | 12.31 | 0.1852 | 1.04 | 2.46 | 711,687.90 | 2.50 | 21.18 | 2.81 | 24.37 | 73.70 | 68.60 | 13.49 | 40.51 | 4.49 | -- | 0.1716 | 25.74 | 44.78 | 31.89 | -24.23 | 47.50 | 65.28 | -- |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.82bn | 2.34k | 141.27 | 5.34 | -- | 13.99 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
| Shanghai Microport EP MedTech Co Ltd | 458.70m | 52.26m | 11.27bn | 500.00 | 215.67 | 6.29 | -- | 24.57 | 0.111 | 0.111 | 0.9747 | 3.81 | 0.2395 | 1.33 | 6.85 | 917,403.00 | 2.73 | 0.9084 | 2.91 | 0.9579 | 58.24 | 64.95 | 11.39 | 4.09 | 10.17 | -- | 0.0032 | 0.00 | 25.51 | 28.61 | 815.36 | -- | 35.67 | -- |
| Eyebright Medical Technlgy (Bjng) Co Ltd | 1.48bn | 360.97m | 11.55bn | 2.29k | 31.70 | 4.11 | -- | 7.81 | 1.88 | 1.88 | 7.71 | 14.53 | 0.4048 | 1.89 | 3.34 | 644,799.40 | 9.90 | 10.50 | 11.54 | 12.04 | 62.91 | 75.13 | 24.45 | 31.92 | 3.28 | 24.66 | 0.1753 | 20.11 | 48.24 | 48.51 | 27.77 | 42.25 | 18.40 | -- |
| Beijing Hotgen Biotech Co Ltd | 434.45m | -259.33m | 11.64bn | 903.00 | -- | 3.97 | -- | 26.79 | -3.04 | -3.04 | 4.98 | 31.63 | 0.1313 | 1.96 | 4.23 | 481,114.30 | -7.97 | 21.79 | -8.47 | 24.93 | 56.38 | 55.43 | -60.71 | 29.14 | 4.77 | -- | 0.0168 | 44.35 | -6.74 | 19.41 | -760.40 | -- | -10.29 | -- |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.48bn | 266.86m | 11.95bn | 2.07k | 44.77 | 2.93 | -- | 8.10 | 0.6672 | 0.6672 | 3.70 | 10.18 | 0.2919 | 0.7798 | 5.17 | 714,278.40 | 5.36 | 9.00 | 6.58 | 11.05 | 64.22 | 74.07 | 18.37 | 24.98 | 4.28 | -- | 0.0011 | 22.90 | 13.18 | -1.59 | 99.22 | -12.72 | -3.40 | -- |
| TINAVI Medical Technologies Co Ltd | 274.20m | -159.01m | 12.54bn | 307.00 | -- | 10.04 | -- | 45.75 | -0.3493 | -0.3493 | 0.6035 | 2.74 | 0.1673 | 2.18 | 7.63 | 893,155.40 | -10.37 | -8.02 | -11.54 | -9.16 | 70.09 | 69.64 | -62.01 | -63.51 | 2.94 | -15.75 | 0.1408 | -- | -14.85 | -4.87 | 22.54 | -- | 12.71 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.47bn | 74.75m | 12.91bn | 2.01k | 167.42 | 3.48 | -- | 8.77 | 0.1647 | 0.1647 | 3.29 | 7.93 | 0.2778 | 1.92 | 2.35 | 730,874.40 | 1.07 | 1.24 | 1.51 | 1.76 | 67.29 | 68.07 | 3.85 | 4.20 | 1.60 | 4.90 | 0.0219 | 0.00 | -0.2705 | 2.71 | -5.73 | 15.09 | -11.35 | -- |
Data as of Mar 03 2026. Currency figures normalised to Eyebright Medical Technology (Beijing) Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
18.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 8.18m | 4.32% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 5.12m | 2.70% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 4.70m | 2.48% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 4.42m | 2.33% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 4.10m | 2.17% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 3.61m | 1.91% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.79m | 0.95% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 1.31m | 0.69% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 1.21m | 0.64% |
| Bosera Asset Management Co., Ltd.as of 12 Nov 2025 | 898.40k | 0.47% |
More ▼
Data from 30 Jun 2025 - 20 Feb 2026Source: FactSet Research Systems Inc.
